Aflibercept
The Endurance 1 Trial
Approved small_molecule completed
Quick answer
Aflibercept for Diabetic Macular Edema is a Approved program (small_molecule) at Regeneron UK Limited with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Regeneron UK Limited
- Indication
- Diabetic Macular Edema
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed